Stephan D. Parent
45Patents
7h-index
80Co-inventors
68Inventor score
Filing activity: May 8, 2006 → Mar 29, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088824B2 | Forms of CDDO methyl ester | Chemistry; Metallurgy | 50 | Active |
| US8309601B2 | Forms of CDDO methyl ester | Chemistry; Metallurgy | 39 | Active |
| US9447071B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Chemistry; Metallurgy | 31 | Active |
| US10137118B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Chemistry; Metallurgy | 20 | Active |
| US8063227B2 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents | Chemistry; Metallurgy | 18 | Active |
| US8633243B2 | Forms of CDDO methyl ester | Chemistry; Metallurgy | 17 | Active |
| US8227482B1 | Forms of rifaximin and uses thereof | Emerging Cross-Sectional Technologies | 10 | Active |
| US8513275B2 | Forms of rifaximin and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9133217B2 | Forms of rifaximin and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8507517B2 | Forms of rifaximin and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8735419B2 | Forms of rifaximin and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US8815888B2 | Forms of rifaximin and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11117909B2 | Crystals | Chemistry; Metallurgy | 3 | Active |
| US8003700B2 | Colchicine solid complex; methods of making; and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US8927761B2 | Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same | Chemistry; Metallurgy | 2 | Active |
| US11028050B2 | Salts and polymorphs of a PDE4 inhibitor | Chemistry; Metallurgy | 2 | Active |
| US11725018B2 | Crystals | Chemistry; Metallurgy | 2 | Active |
| US8829197B2 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents | Chemistry; Metallurgy | 1 | Active |
| US9211290B2 | Solid dispersions of amorphous paroxetine mesylate | Human Necessities | 1 | Active |
| US10722502B2 | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Chemistry; Metallurgy | 1 | Active |
| US8710087B2 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents | Chemistry; Metallurgy | 1 | Active |
| US9012469B2 | Crystalline naloxol-peg conjugate | Chemistry; Metallurgy | 1 | Active |
| US8846731B2 | Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents | Chemistry; Metallurgy | 1 | Active |
| US8883783B2 | Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith | Chemistry; Metallurgy | 1 | Active |
| US7605270B2 | Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.